Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma is a research paper published in BMC Gastroenterology (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Chinese Society of Clinical Oncology
Grant: 2018074
MeSH Terms
Keywords
Additional file 1 of Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma
Additional file 2 of Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma
Additional file 1 of Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma
Additional file 2 of Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma
Additional file 3 of Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma
Additional file 4 of Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma
Additional file 3 of Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma
Additional file 4 of Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma